Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography
Primary Purpose
Pulmonary Arterial Hypertension
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
2D doppler echo with Definity solution
Sponsored by
About this trial
This is an interventional diagnostic trial for Pulmonary Arterial Hypertension focused on measuring Pulmonary Arterial Hypertension, Pulmonary Vascular Resistance, Right Heart Catheterization
Eligibility Criteria
Inclusion Criteria:
- Adult patients scheduled to undergo right heart catheterization at the George Washington University Hospital
Exclusion Criteria:
- Patients with known or suspected right-to-left bi-directional or transient right-to-left shunts or pulmonary arteriovenous malformations, previously documented moderate to severe tricuspid regurgitation or moderate to severe pulmonary regurgitation, evidence of right ventricular hypokinesis, or prior adverse reaction to Definity or hypersensitivity to perflutren
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
2D doppler echo with Definity solution
Arm Description
Study subjects will already be scheduled for right heart catheterization to diagnose pulmonary hypertension. Prior to the catheterization, each subject will have a 2D doppler echocardiogram with Definity solution as well.
Outcomes
Primary Outcome Measures
Measure Pulmonary Vascular Resistance using 2D Doppler Echocardiogram w/Definity Solution
Correlation coefficients between the technique above the the gold standard right heart catheterization measures of pulmonary vascular resistance.
Secondary Outcome Measures
Full Information
NCT ID
NCT02028299
First Posted
August 20, 2013
Last Updated
January 3, 2014
Sponsor
George Washington University
1. Study Identification
Unique Protocol Identification Number
NCT02028299
Brief Title
Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography
Official Title
Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography
Study Type
Interventional
2. Study Status
Record Verification Date
April 2013
Overall Recruitment Status
Completed
Study Start Date
April 2010 (undefined)
Primary Completion Date
July 2012 (Actual)
Study Completion Date
July 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
George Washington University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
An echocardiogram using Definity contrast can provide the same information as the standard right heart catheterization.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Arterial Hypertension
Keywords
Pulmonary Arterial Hypertension, Pulmonary Vascular Resistance, Right Heart Catheterization
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
38 (Actual)
8. Arms, Groups, and Interventions
Arm Title
2D doppler echo with Definity solution
Arm Type
Experimental
Arm Description
Study subjects will already be scheduled for right heart catheterization to diagnose pulmonary hypertension. Prior to the catheterization, each subject will have a 2D doppler echocardiogram with Definity solution as well.
Intervention Type
Procedure
Intervention Name(s)
2D doppler echo with Definity solution
Other Intervention Name(s)
Definity solution
Intervention Description
Correlate right heart catheterization results with results from 2D doppler echo with Definity Solution
Primary Outcome Measure Information:
Title
Measure Pulmonary Vascular Resistance using 2D Doppler Echocardiogram w/Definity Solution
Description
Correlation coefficients between the technique above the the gold standard right heart catheterization measures of pulmonary vascular resistance.
Time Frame
Two Years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult patients scheduled to undergo right heart catheterization at the George Washington University Hospital
Exclusion Criteria:
Patients with known or suspected right-to-left bi-directional or transient right-to-left shunts or pulmonary arteriovenous malformations, previously documented moderate to severe tricuspid regurgitation or moderate to severe pulmonary regurgitation, evidence of right ventricular hypokinesis, or prior adverse reaction to Definity or hypersensitivity to perflutren
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brian Choi, MD
Organizational Affiliation
Medical Faculty Associates, Inc.
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Estimation of Pulmonary Vascular Resistance by Contrast Echocardiography
We'll reach out to this number within 24 hrs